Sandoz Leadership
Under the leadership of Richard Saynor, the Sandoz Executive Committee (SEC) is responsible for overseeing the business operations of Sandoz. The SEC is made up of a diverse team of leaders with extensive experience in the generic pharmaceutical and biopharmaceutical industry. Each member of the SEC represents a specific region, business unit or global function. They share a commitment to helping people around the world access high quality medicine.
Richard Saynor
CEO, Sandoz
Francisco Ballester
Head of International Region
Giovanni Barbella
Technical Operations
Martin Bischof
Head of Ethics, Risk and Compliance
Colin Bond
Chief Financial Officer
Pierre Bourdage
Global Head of Biopharmaceuticals
Valerie Chew
Chief Digital Officer
Tatiana Eliseeva
Chief Transformation Officer
Rebecca Guntern
Head of Region Europe
Keren Haruvi
President of Sandoz US and Head of North America
Steffen Kurzawa
Chief Communications Officer
Carol Lynch
Chief Business Officer
Inge Maes
Global Head People & Organization
Ingrid Sollerer
General Counsel & Global Head of Legal